Literature DB >> 21568356

The appropriate elicitation of expert opinion in economic models: making expert data fit for purpose.

William Sullivan1, Katherine Payne.   

Abstract

Mesh：

Year:  2011        PMID： 21568356     DOI： 10.2165/11589220-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  17 in total

1.  Expert judgement in pharmacoeconomic studies. Guidance and future use.

Authors:  C Evans; B Crawford
Journal:  Pharmacoeconomics       Date:  2000-06       Impact factor: 4.981

2.  The iterative use of economic evaluation as part of the process of health technology assessment.

Authors:  M Sculpher; M Drummond; M Buxton
Journal:  J Health Serv Res Policy       Date:  1997-01

3.  Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

Authors:  Karl Claxton; Mark Sculpher; Chris McCabe; Andrew Briggs; Ron Akehurst; Martin Buxton; John Brazier; Tony O'Hagan
Journal:  Health Econ       Date:  2005-04       Impact factor: 3.046

Review 4.  Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment.

Authors:  Zoë Philips; Laura Bojke; Mark Sculpher; Karl Claxton; Su Golder
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  The value of implementation and the value of information: combined and uneven development.

Authors:  Elisabeth Fenwick; Karl Claxton; Mark Sculpher
Journal:  Med Decis Making       Date:  2008 Jan-Feb       Impact factor: 2.583

Review 6.  Characterizing structural uncertainty in decision analytic models: a review and application of methods.

Authors:  Laura Bojke; Karl Claxton; Mark Sculpher; Stephen Palmer
Journal:  Value Health       Date:  2009 Jul-Aug       Impact factor: 5.725

7.  Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.

Authors:  Laura Vallejo-Torres; Lotte M G Steuten; Martin J Buxton; Alan J Girling; Richard J Lilford; Terry Young
Journal:  Int J Technol Assess Health Care       Date:  2008       Impact factor: 2.188

8.  Fish and chips all round? Regulation of DNA-based genetic diagnostics.

Authors:  Katherine Payne
Journal:  Health Econ       Date:  2009-11       Impact factor: 3.046

Review 9.  The Delphi technique: a critique.

Authors:  C M Goodman
Journal:  J Adv Nurs       Date:  1987-11       Impact factor: 3.187

10.  Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom.

Authors:  F H Shabaruddin; R A Elliott; J W Valle; W G Newman; K Payne
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640
View more
  14 in total

Review 1.  Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.

Authors:  Eleanor M Heather; Katherine Payne; Mark Harrison; Deborah P M Symmons
Journal:  Pharmacoeconomics       Date:  2014-02       Impact factor: 4.981

Review 2.  Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment.

Authors:  Bogdan Grigore; Jaime Peters; Christopher Hyde; Ken Stein
Journal:  Pharmacoeconomics       Date:  2013-11       Impact factor: 4.981

3.  How Qualitative Methods Can be Used to Inform Model Development.

Authors:  Samantha Husbands; Susan Jowett; Pelham Barton; Joanna Coast
Journal:  Pharmacoeconomics       Date:  2017-06       Impact factor: 4.981

4.  Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties.

Authors:  Laura Bojke; Bogdan Grigore; Dina Jankovic; Jaime Peters; Marta Soares; Ken Stein
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

5.  Where is genetic medicine headed? Exploring the perspectives of Canadian genetic professionals on future trends using the Delphi method.

Authors:  Kennedy Borle; Nicola Kopac; Nick Dragojlovic; Elisabet Rodriguez Llorian; Jan M Friedman; Alison M Elliott; Larry D Lynd
Journal:  Eur J Hum Genet       Date:  2022-01-15       Impact factor: 5.351

6.  Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations.

Authors:  Cynthia P Iglesias; Alexander Thompson; Wolf H Rogowski; Katherine Payne
Journal:  Pharmacoeconomics       Date:  2016-11       Impact factor: 4.981

7.  Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis.

Authors:  Andrés Pichon-Riviere; Demián Glujovsky; Osvaldo Ulises Garay; Federico Augustovski; Agustin Ciapponi; Magdalena Serpa; Fernando Althabe
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

Review 8.  Economic evaluation in chronic pain: a systematic review and de novo flexible economic model.

Authors:  W Sullivan; M Hirst; S Beard; D Gladwell; F Fagnani; J López Bastida; C Phillips; W C N Dunlop
Journal:  Eur J Health Econ       Date:  2015-09-16

Review 9.  Economic evaluations of personalized medicine: existing challenges and current developments.

Authors:  Fatiha H Shabaruddin; Nigel D Fleeman; Katherine Payne
Journal:  Pharmgenomics Pers Med       Date:  2015-06-24

10.  A comparison of two methods for expert elicitation in health technology assessments.

Authors:  Bogdan Grigore; Jaime Peters; Christopher Hyde; Ken Stein
Journal:  BMC Med Res Methodol       Date:  2016-07-26       Impact factor: 4.615
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.